Generate Biomedicines, Inc. (GENB) Financials
GENB Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 561.7 million | 105.6 million |
| March 31, 2026 | 625.7 million | 110.9 million |
| June 30, 2025 | ? | ? |
| March 31, 2025 | ? | ? |
GENB Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -58.9 million | 8.2 million |
| March 31, 2026 | -84.2 million | 6.4 million |
| June 30, 2025 | -48.9 million | 5.5 million |
| March 31, 2025 | -53.9 million | 4.7 million |
GENB Net Income
No data available :(
GENB Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 457.4 million | - | 62.6 million |
| March 31, 2026 | 516.6 million | - | 51.3 million |
| June 30, 2025 | - | - | - |
| March 31, 2025 | - | - | - |
GENB Shares Outstanding
GENB Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 933000 | 64.3 million | 13.6 million | - |
| March 31, 2026 | 3.8 million | 54.6 million | 13.5 million | - |
| June 30, 2025 | 154000 | 59.7 million | 10.5 million | - |
| March 31, 2025 | 751000 | 46.8 million | 10.1 million | - |
GENB Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 6.3 million | - |
| March 31, 2026 | 7.2 million | 3.3 million |
| June 30, 2025 | 10.1 million | - |
| March 31, 2025 | 8.8 million | - |
GENB
Price: $16.49
52 week price:
Earnings Per Share: -2.03 USD
Exchange: NGM
Sector: Financial Services
Industry: Asset Management
Market Capitalization: 1.8 billion